Baxter International (BAX) Stock Forecast & Price Target

$19.37 +0.19 (+0.99%)

As of 11:40 AM Eastern

Compare

Baxter International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Reduce

Based on 13 Analyst Ratings

Sell
3

Hold
8

Buy
2

Based on 13 Wall Street analysts who have issued ratings for Baxter International in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 13 analysts, 3 have given a sell rating, 8 have given a hold rating, and 2 have given a buy rating for BAX.

Consensus Price Target

$19.91
2.78% Upside

According to the 13 analysts' twelve-month price targets for Baxter International, the average price target is $19.91. The highest price target for BAX is $27.00, while the lowest price target for BAX is $15.00. The average price target represents a forecasted upside of 2.78% from the current price of $19.37.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for BAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Baxter International and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BAX Analyst Ratings Over Time

Type	Current Forecast 5/26/25 to 5/26/26	1 Month Ago 4/26/25 to 4/26/26	3 Months Ago 2/25/25 to 2/25/26	1 Year Ago 5/26/24 to 5/26/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	5 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)	3 Hold rating(s)
Sell	3 Sell rating(s)	3 Sell rating(s)	3 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$19.91	$19.80	$20.10	$37.25
Forecasted Upside	2.78% Upside	8.99% Upside	-3.18% Downside	23.52% Upside
Consensus Rating	Reduce	Reduce	Reduce	Hold

BAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Baxter International Stock vs. The Competition

Type	Baxter International	Medical Companies	Broader Market
Consensus Rating Score	1.92	2.30	2.52
Consensus Rating	Reduce	Hold	Moderate Buy
Predicted Upside	3.75% Upside	1,718.95% Upside	15.10% Upside
News Sentiment Rating	Neutral News See Recent BAX News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/15/2026	Weiss Ratings Not Rated		Reiterated Rating	Sell (E+)
5/1/2026	TD Cowen 3 of 5 stars		Lower Target		$22.00 ➝ $20.00	+15.91%
5/1/2026	Stifel Nicolaus 4 of 5 stars		Lower Target		$20.00 ➝ $19.00	+10.11%
5/1/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target		$17.00 ➝ $19.00	+10.11%
5/1/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$25.00 ➝ $27.00	+56.48%
4/24/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold ➝ Strong Sell
4/6/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Outperform	$23.00 ➝ $22.00	+32.09%
3/11/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$21.00 ➝ $19.00	+6.24%
2/13/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Hold	$21.00 ➝ $19.00	+1.04%
12/12/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$21.00 ➝ $19.00	-0.29%
Get the Latest News and Ratings for BAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.
12/2/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Underweight	$19.00 ➝ $15.00	-20.83%
10/31/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$25.00 ➝ $19.00	+2.90%
10/31/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Danielle Antalffy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$24.00 ➝ $21.00	+11.75%
10/31/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jasper Hellweg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:00 PM ET.

Should I Buy Baxter International Stock? BAX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, May 19, 2026. Please send any questions or comments about these Baxter International pros and cons to contact@marketbeat.com.

Baxter International
Bull Case

Here are some ways that investors could benefit from investing in Baxter International Inc.:

The current stock price is around $17.97, which is near its 12-month low of $15.73, potentially offering a buying opportunity for investors looking for value.
Baxter International Inc. recently reported quarterly earnings that exceeded analysts' expectations, with earnings per share of $0.36 compared to a consensus estimate of $0.31, indicating strong financial performance.
The company experienced a year-over-year revenue increase of 2.9%, demonstrating resilience and growth in its medical products and therapies segment.
With a positive return on equity of approximately 15.65%, Baxter International Inc. shows effective management in generating profits from shareholders' equity.
Institutional investors hold a significant portion of the company's stock, with 90.19% ownership, suggesting confidence in Baxter International Inc.'s long-term prospects.

Baxter International
Bear Case

Investors should be bearish about investing in Baxter International Inc. for these reasons:

The company has a negative net margin of 9.70%, which indicates that it is currently spending more than it earns, raising concerns about profitability.
Recent ratings from analysts have been mixed, with Zacks Research downgrading the stock to a "strong sell," reflecting bearish sentiment in the market.
The P/E ratio is negative, which can be a red flag for investors as it suggests that the company is not currently generating profits relative to its share price.
Target prices from analysts have been lowered, with some estimates dropping to around $19.00, indicating a lack of confidence in significant price appreciation in the near term.
The company has a relatively high debt-to-equity ratio of 1.55, which may pose risks if the company faces financial difficulties or rising interest rates.

BAX Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Baxter International is $19.91, with a high forecast of $27.00 and a low forecast of $15.00.

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 3 sell ratings, 8 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" BAX shares.

According to analysts, Baxter International's stock has a predicted upside of 2.78% based on their 12-month stock forecasts.

Over the previous 90 days, Baxter International's stock had 1 upgrade and 1 downgrade by analysts.

Baxter International has been rated by research analysts at Barclays, Citigroup, Evercore, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Baxter International less than other "medical" companies. The consensus rating for Baxter International is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how BAX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Baxter International Recommendations

This page (NYSE:BAX) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baxter International (BAX) Stock Forecast & Price Target

Baxter International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

BAX Analyst Ratings Over Time

BAX Analyst Recommendations By Month

BAX Price Targets by Month

Baxter International Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Baxter International Stock? BAX Pros and Cons Explained

Baxter International
Bull Case

Baxter International
Bear Case

BAX Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Baxter International Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baxter International (BAX) Stock Forecast & Price Target

Baxter International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

BAX Analyst Ratings Over Time

BAX Analyst Recommendations By Month

BAX Price Targets by Month

Baxter International Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Baxter International Stock? BAX Pros and Cons Explained

Baxter International Bull Case

Baxter International Bear Case

BAX Forecast - Frequently Asked Questions

What is Baxter International's forecast for 2026?

Should I buy or sell Baxter International stock right now?

Does Baxter International's stock price have much upside?

Has Baxter International been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Baxter International?

Do Wall Street analysts like Baxter International more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Baxter International Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Baxter International
Bull Case

Baxter International
Bear Case